Press Releases
2011
18, August 2011
november AG continues on its path to success/Publication of the consolidated financial statements for the first half-year 2011
05, August 2011
Extended Field of Application of PROGEN Hantavirus Diagnostics
07, April 2011
Annual Shareholders´ Meeting May 17, 2011 in Cologne
31, March 2011
november AG 2010: Balanced Result And Especially Successful Operating Business Result
2010
12, November 2010
november AG/PROGEN Biotechnik GmbH – Significant Increase of 3rd Quarter Operating Results
27, October 2010
PROGEN signs exclusive distribution agreement with Asuragen
01, September 2010
New Tests for Diagnosis of Borreliosis
New Tests for Diagnosis of Borreliosis
approved for use as CE IVD Products
09, August 2010
Half-Year Results 2010 Confirm: november AG On Target Publication of consolidated operating results as of June 30, 2010
03, May 2010
Publication of consolidated financial results for 2009 / Continued upswing of november AG
29, March 2010
Capital contribution successfully completed /
Capital contribution successfully completed /
Management Board confirmed for another 3 years
25, January 2010
Research update: recommendation „buy“, target price € 2,32
2009
10, November 2009
The positive trend of the november AG continues through the 3rd quarter
12, October 2009